Hosted on MSN24d
Biomarker algorithm for Barrett's esophagus and esophageal cancer developed
"Our study used a methodically rigorous process to identify biomarkers, and we believe this represents the first study to select biomarkers for Barrett's esophagus, esophageal adenocarcinoma and ...
Medscape12y
Endoscopic Therapies for Barrett's-Associated Dysplasia
Recent American Gastroenterological Association guidelines support the treatment of confirmed low-grade dysplasia. Ablation of non-dysplastic Barrett's esophagus may be appropriate in high-risk ...
EurekAlert!24d
Researchers develop biomarker algorithm for noninvasive detection of Barrett’s esophagus and esophageal cancer
Extending the ability to identify healthy control patients versus patients with Barrett’s esophagus and high-grade dysplasia or esophageal cancer combined, the AUC was 0.86, which Meltzer says ...
American Journal Of Gastroenterology Publishes Key Study Further Validating Esopredict® As A Prognostic Test For Barrett's Esophagus
In this publication, titled Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Barrett's Esophagus Patients, Esopredict was performed at multiple locations and time ...
Cancer Research UK11mon
A trial looking at the capsule sponge test to monitor Barrett’s oesophagus (BEST4 Surveillance)
People with Barrett’s oesophagus usually have regular endoscopies to monitor it. The team take small tissue samples (biopsies). They look for early changes in the cells. This is called dysplasia.